The size of the global spinal fusion devices market is expected to grow at a CAGR of 5.12% from 2024 to 2029 and be worth USD 6.42 billion in 2024 and USD 8.24 billion by 2029.
Spinal fusion is a surgical treatment that involves fusing two or more vertebrae to prevent them from moving. The surgery is advised to treat pain caused by improper vertebral mobility. Although the technique is most typically used to treat the lumbar region, it can also treat the cervical and thoracic vertebrae in cases of accident damage or to relieve pressure on the nerves. Degenerative disc disease, spinal tumor, spondylosis, and vertebral fracture are other disorders for orthopedic surgeons to propose spinal fusion.
The growing aging population across the globe is fuelling the global spinal fusion devices market growth.
Due to the lower birth rates and longer life expectancies, the global population is rapidly aging. The aging population's demographic trend drives the growing need for therapy for old age-related spine problems. In addition, physiological changes and long-term exposure to risk factors raise the likelihood of developing spine diseases, necessitating surgery. As a result, the market under consideration may be primarily driven by the aging population and the rise in spine diseases. In addition, increased spine pain and other disorders have come from increased vehicle accidents, sedentary lifestyles, and inconsistent exercise.
Minimally invasive procedures have grown in popularity since they are less unpleasant and allow for faster recovery. Surgeons choose MIS over open surgery for various reasons, including less pain, a shorter recovery time, and minor tissue injury. Although surgeons now use a traditional approach to surgery, increasing doctors' and patients' understanding of minimally invasive techniques is estimated to accelerate market growth in the near future. Cervical fixation devices, thoracolumbar fixation devices, interbody devices, and biologics are all spine fusion devices. The other key drivers for the market's growth include rising demand for cervical and thoracolumbar devices and advancements in interbody devices. For example, the FDA granted Stryker 510(k) approval for the SAHARA Lateral 3D Expandable Interbody System, a 3D-printed spine fusion implant.
However, the growth of the global spinal fusion devices market is projected to be limited by unfavorable reimbursement scenarios and complex regulatory approval procedures for these devices. Furthermore, difficulties that can occur include infection, bleeding, and anesthesia complications, as they would be with any surgery. In addition, any form of nerve injury is another possible consequence of low back spinal fusion surgery.
The COVID-19 pandemic has had a significant influence on practically every business. The market for spinal fusion devices, like other healthcare markets, has been severely impacted. COVID-19 has resulted in elective surgeries being postponed or deferred, a drop in sales, and a slowed growth rate, among other things. The demand for spinal fusion devices and equipment has declined significantly as surgical procedures have decreased. The COVID-19 pandemic has had a significant impact on expanding the number of markets, and the outbreak's immediate consequences are diverse. While demand in a few businesses has decreased, a wealth of other industries may continue to prosper and give expansion opportunities. Initially, the global COVID-19 outbreak and lockdown situation in some countries presented some challenges on the market, owing to a moratorium on orthopedic services by hospitals and clinics to prevent the spread of the COVID-19 virus, as well as the tremendous pressure on hospitals to provide services to COVID-19 patients, which has been inhibiting hospitals and clinics.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Surgery, Product, End-User, Disease & Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Market Leaders Profiled |
A few of the prominent companies operating in the global spinal fusion devices market profiled in this report are Stryker Corporation, Medtronic, Zimmer Biomet, Depuy Synthes Companies, Globus Medical, B. Braun Aesculap, Nuvasive, K2M, MicroPort, Orthofix International N.V., Alphatec Spine, Integra LifeSciences, Invibio, and Weigao Orthopaedic. |
Based on the product, the lumbar fusion segment is expected to grow at a healthy rate during the forecast period. Lumbar fusion is a complicated procedure that needs the placement of screws between the united vertebrae. After that, the bone graft is put around the screws. Titanium screws are utilized during this procedure, and they are usually left in place for the rest of one's life. These procedures are more dangerous than basic laminectomies or discectomies. After this treatment, the recovery time is usually lengthier, and the operating time might range from four to eight hours. It has been discovered that developing countries, such as India, provide advanced medical services at the most affordable prices.
In 2024, the degenerative disc segment dominated the market for spinal fusion devices. The segment is predicted to be driven by growing reasons for lower back and neck discomfort in adults and an increase in the senior population. In addition, the growth of sports and daily activities is predicted to contribute to segment expansion.
Because minimally invasive spine surgery is the preferred method for spinal fusion surgeries, it led the market for spinal fusion devices in 2024, accounting for 69.0 percent of total revenues.
In 2024, hospitals dominated the market for spinal fusion devices. One of the elements propelling the market is the increasing number of spine procedures conducted in hospitals. In addition, in emerging countries like India, growing government measures to improve healthcare infrastructure and expand the middle-class population result in increased demand for excellent healthcare services offered by hospitals, helping the segment grow.
Geographically, the North American regional market dominated the global spinal fusion devices market in 2022. The growing geriatric population, the rise in spinal disorders, and sports injuries and fatal accidents are all driving up demand for spinal fusion devices in North America. Furthermore, the rising rate of spine surgery in the US has been well documented. Technological advancements, senior patients anticipating better levels of function, and reimbursement structures that promote sophisticated fusion surgery have all contributed to the expansion of the spinal surgery industry in the United States.
The market for spinal fusion devices in the Asia Pacific is predicted to increase rapidly over the forecast period. The increase can be ascribed to a rise in medical tourism and government measures. Furthermore, the region's growing target population raises the risk of spinal diseases and joint problems. Over the forecast period, the market for spinal fusion devices in India is expected to rise at a healthy rate. Increased medical tourism to India for spinal fusion operations is blamed for the growth.
A few of the prominent companies operating in the global spinal fusion devices market profiled in this report are Stryker Corporation, Medtronic, Zimmer Biomet, Depuy Synthes Companies, Globus Medical, B. Braun Aesculap, Nuvasive, K2M, MicroPort, Orthofix International N.V., Alphatec Spine, Integra LifeSciences, Invibio, and Weigao Orthopaedic.
Open spine surgery
Frequently Asked Questions
The global spinal fusion devices market was valued at USD 5.82 billion in 2022.
The growth of the spinal fusion devices market is being driven by factors such as the increasing prevalence of spinal disorders, the aging population, and advances in surgical techniques and technology.
The key players in the spinal fusion devices market include companies such as Medtronic, DePuy Synthes, Stryker, Zimmer Biomet, and NuVasive.
Some of the challenges faced by the spinal fusion devices market include regulatory hurdles, the high cost of spinal fusion surgeries, and concerns about the long-term efficacy and safety of spinal fusion procedures.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region